rs61752254

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_012179.4(FBXO7):​c.693C>T​(p.Ser231Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00441 in 1,614,128 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 12 hom. )

Consequence

FBXO7
NM_012179.4 synonymous

Scores

3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -5.91

Publications

4 publications found
Variant links:
Genes affected
FBXO7 (HGNC:13586): (F-box protein 7) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it may play a role in regulation of hematopoiesis. Alternatively spliced transcript variants of this gene have been identified with the full-length natures of only some variants being determined. [provided by RefSeq, Jul 2008]
FBXO7 Gene-Disease associations (from GenCC):
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_012179.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 22-32485115-C-T is Benign according to our data. Variant chr22-32485115-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 341312.
BP7
Synonymous conserved (PhyloP=-5.91 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0028 (426/152260) while in subpopulation NFE AF = 0.00481 (327/68014). AF 95% confidence interval is 0.00438. There are 1 homozygotes in GnomAd4. There are 187 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012179.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO7
NM_012179.4
MANE Select
c.693C>Tp.Ser231Ser
synonymous
Exon 4 of 9NP_036311.3
FBXO7
NM_001033024.2
c.456C>Tp.Ser152Ser
synonymous
Exon 4 of 9NP_001028196.1Q9Y3I1-2
FBXO7
NM_001257990.2
c.351C>Tp.Ser117Ser
synonymous
Exon 4 of 9NP_001244919.1Q9Y3I1-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO7
ENST00000266087.12
TSL:1 MANE Select
c.693C>Tp.Ser231Ser
synonymous
Exon 4 of 9ENSP00000266087.7Q9Y3I1-1
FBXO7
ENST00000886524.1
c.693C>Tp.Ser231Ser
synonymous
Exon 4 of 10ENSP00000556583.1
FBXO7
ENST00000920428.1
c.693C>Tp.Ser231Ser
synonymous
Exon 4 of 9ENSP00000590487.1

Frequencies

GnomAD3 genomes
AF:
0.00280
AC:
426
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00481
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00285
AC:
716
AN:
251442
AF XY:
0.00280
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.000810
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00268
Gnomad NFE exome
AF:
0.00492
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00458
AC:
6695
AN:
1461868
Hom.:
12
Cov.:
31
AF XY:
0.00451
AC XY:
3281
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33480
American (AMR)
AF:
0.000760
AC:
34
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.00159
AC:
137
AN:
86258
European-Finnish (FIN)
AF:
0.00234
AC:
125
AN:
53420
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00552
AC:
6143
AN:
1111996
Other (OTH)
AF:
0.00374
AC:
226
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
369
738
1108
1477
1846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00280
AC:
426
AN:
152260
Hom.:
1
Cov.:
32
AF XY:
0.00251
AC XY:
187
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41564
American (AMR)
AF:
0.000850
AC:
13
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4824
European-Finnish (FIN)
AF:
0.00255
AC:
27
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00481
AC:
327
AN:
68014
Other (OTH)
AF:
0.00238
AC:
5
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00470
Hom.:
1
Bravo
AF:
0.00281
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00507
EpiControl
AF:
0.00415

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Parkinsonian-pyramidal syndrome (4)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
FBXO7-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.19
DANN
Benign
0.56
PhyloP100
-5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61752254;
hg19: chr22-32881102;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.